Everest Medicines Ltd (HKSE:01952)
HK$ 44.65 4.05 (9.98%) Market Cap: 14.39 Bil Enterprise Value: 11.54 Bil PE Ratio: 0 PB Ratio: 3.03 GF Score: 41/100

Q4 2023 Everest Medicines Ltd Earnings Call Transcript

Mar 28, 2024 / 01:00AM GMT
Release Date Price: HK$23.5 (+7.31%)
Operator

Good morning or good evening. Welcome to Everest Medicines 2023 Full Year Financial Results Conference Call. Please be reminded that today's conference is being recorded (Operator Instructions) And finally, I would like to hand the conference over to your speaker today. Ms. Leah Liu, if you have the corporate, please go ahead.

Leah Liu
Everest Medicines Ltd - Joint Company Secretary

Thank you. Operator, and good morning or good evening, everyone, and welcome to our 2023 full year financial results conference call. Joining us today are Mr. Rogers Luo, Chief Executive Officer of Everest Medicines; Mr. Ian Woo, President & Chief Financial Officer; Dr. Jennifer Yang, Chief Scientific Officer, and Sandra Zeng, Chief Medical Officer.

Before we get started, I'd like to remind you that the speakers on this call conference call and make statements on forward looking statements, including discussions regarding the intent, belief or current expectations of the company or its officers with respect to the business, operations and financial conditions of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot